Published in Emerg Infect Dis on October 01, 2002
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis (2002) 1.53
Public health in the time of bioterrorism. Emerg Infect Dis (2002) 1.46
Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy. Antimicrob Agents Chemother (2007) 1.28
Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum. Clin Diagn Lab Immunol (2004) 1.21
The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed. Genes Immun (2011) 1.06
Validation of high throughput sequencing and microbial forensics applications. Investig Genet (2014) 1.02
Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001. Emerg Infect Dis (2003) 1.02
Quality sample collection, handling, and preservation for an effective microbial forensics program. Appl Environ Microbiol (2006) 0.96
Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay. Occup Environ Med (2004) 0.83
The value of postmortem microbiology cultures. J Clin Microbiol (2014) 0.82
Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review. Health Secur (2015) 0.81
Facilitation of risk communication during the anthrax attacks of 2001: the organizational backstory. Am J Public Health (2007) 0.78
Genomic copy number variants: evidence for association with antibody response to anthrax vaccine adsorbed. PLoS One (2013) 0.76
Historical Data Analysis of Hospital Discharges Related to the Amerithrax Attack in Florida. Perspect Health Inf Manag (2016) 0.75
Bioterrorism: a laboratory who does it? J Clin Microbiol (2014) 0.75
Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J Bacteriol (2000) 15.34
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73
Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep (2001) 6.49
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76
Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med (2001) 2.71
Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.23
Update: Investigation of bioterrorism-related anthrax, 2001. MMWR Morb Mortal Wkly Rep (2001) 2.01
Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure. Mil Med (1999) 1.06
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (2013) 12.46
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci U S A (2004) 4.73
Neurologic manifestations and outcome of West Nile virus infection. JAMA (2003) 4.61
Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol (2003) 4.47
The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2008) 3.79
Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA (2002) 3.26
Characterization of Bacillus cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and harbor B. anthracis virulence genes. J Clin Microbiol (2006) 3.15
Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis (2005) 3.15
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology (2013) 3.02
Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol (2003) 3.01
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Molecular subtyping of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States. Emerg Infect Dis (2002) 2.99
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. JAMA (2008) 2.88
Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis (2004) 2.88
Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis (2002) 2.88
Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine (2010) 2.86
The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, Nepal. Am J Trop Med Hyg (2004) 2.77
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76
Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis (2008) 2.73
Sequencing of 16S rRNA gene: a rapid tool for identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.54
Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000. Emerg Infect Dis (2003) 2.35
Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis (2003) 2.34
The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology (2012) 2.31
West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis (2006) 2.30
Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis (2004) 2.29
Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.23
Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol (2004) 2.20
Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge. Sci Transl Med (2012) 2.17
Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2003) 2.15
Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol (2003) 2.11
Surface sampling methods for Bacillus anthracis spore contamination. Emerg Infect Dis (2002) 2.11
Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis (2002) 2.03
Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis (2002) 2.02
Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates. J Clin Microbiol (2004) 1.97
The scientific basis for law as a public health tool. Am J Public Health (2008) 1.91
Infectious disease hospitalizations among infants in the United States. Pediatrics (2008) 1.90
Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerg Infect Dis (2002) 1.89
West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. J Infect Dis (2010) 1.88
Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis (2003) 1.84
Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol (2002) 1.83
Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis (2003) 1.81
Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2010) 1.79
Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A (2002) 1.77
Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis (2006) 1.76
Impact of a New York City Health Department initiative to expand HIV partner services outside STD clinics. Public Health Rep (2012) 1.76
An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol (2009) 1.73
Quantitative evaluation of bacteria released by bathers in a marine water. Water Res (2006) 1.66
Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization. J Immunol Methods (2008) 1.64
Detection of Bacillus anthracis DNA by LightCycler PCR. J Clin Microbiol (2002) 1.63
Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol (2011) 1.62
Detection of smallpox virus DNA by LightCycler PCR. J Clin Microbiol (2002) 1.62
One-year health assessment of adult survivors of Bacillus anthracis infection. JAMA (2004) 1.61
Surveillance results from the first West Nile virus transmission season in Florida, 2001. Am J Trop Med Hyg (2003) 1.57
Distribution of eosinophilic meningitis cases attributable to Angiostrongylus cantonensis, Hawaii. Emerg Infect Dis (2007) 1.54
Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis (2002) 1.54
A two-component direct fluorescent-antibody assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 1.54
Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis (2002) 1.53
Bacillus anthracis aerosolization associated with a contaminated mail sorting machine. Emerg Infect Dis (2002) 1.52
Planning against biological terrorism: lessons from outbreak investigations. Emerg Infect Dis (2003) 1.51
A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin Infect Dis (2007) 1.51
Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Microbiol (2003) 1.50
An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program. Pharmacoepidemiol Drug Saf (2005) 1.50
Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol (2003) 1.47
Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol (2005) 1.47
Lost or just not following up: public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care. AIDS (2013) 1.47
Public health in the time of bioterrorism. Emerg Infect Dis (2002) 1.46
Nodding syndrome. Emerg Infect Dis (2013) 1.45
Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool. J Clin Microbiol (2002) 1.45
Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. Clin Diagn Lab Immunol (2004) 1.44
Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial. Obstet Gynecol (2016) 1.44
Infectious disease hospitalizations in the United States. Clin Infect Dis (2009) 1.43
Cell phone-based and internet-based monitoring and evaluation of the National Antiretroviral Treatment Program during rapid scale-up in Rwanda: TRACnet, 2004-2010. J Acquir Immune Defic Syndr (2012) 1.41